BioRestorative Therapies, Inc. (BRTX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 23.17K | 19.6K | 11.8K | 303.3K | 25K | 43.3K | 233.6K | 89.1K | 35K | 19.3K | 30.7K | 64.5K |
| Revenue Growth % | -7.32% | -54.73% | -94.95% | 240.4% | -28.57% | 124.35% | 660.91% | 38.14% | 11.82% | 421.62% | 5.86% | -9.28% |
| Cost of Goods Sold | 7.38K | 1.64K | 10.57K | 8.73K | 2.91K | 3.34K | 18.24K | 6.49K | 0 | 42.71K | 0 | 0 |
| COGS % of Revenue | 31.87% | 8.35% | 89.58% | 2.88% | 11.64% | 7.71% | 7.81% | 7.28% | - | 221.31% | - | - |
| Gross Profit | 15.79K | 17.96K | 1.23K | 294.57K | 22.09K | 39.96K | 215.36K | 82.61K | 35K | -23.41K | 30.7K | 64.5K |
| Gross Margin % | 68.13% | 91.65% | 10.42% | 97.12% | 88.36% | 92.29% | 92.19% | 92.72% | 100% | -121.31% | 100% | 100% |
| Gross Profit Growth % | -28.55% | -55.05% | -99.43% | 256.58% | -36.88% | 270.68% | 601.49% | 28.08% | 11.82% | -732.78% | 5.86% | -9.28% |
| Operating Expenses | 3.4M | 3.84M | 3.71M | 3.6M | 4.83M | 2.73M | 2.5M | 2.55M | 4.14M | 3.2M | 3.14M | 3.18M |
| OpEx % of Revenue | 14680.7% | 19608.49% | 31442.72% | 1186.9% | 19318.5% | 6305.09% | 1071.21% | 2863.54% | 11840.72% | 16566.16% | 10212.19% | 4931.86% |
| Selling, General & Admin | 1.48M | 1.22M | 1.12M | 1.37M | 3.12M | 1.07M | 1.18M | 1.26M | 3.09M | 2.52M | 2.33M | 2.28M |
| SG&A % of Revenue | 6366.88% | 6204.72% | 9453.31% | 453.01% | 12461.19% | 2475.49% | 506.13% | 1413.28% | 8817.49% | 13039.58% | 7574.33% | 3532.03% |
| Research & Development | 1.93M | 2.63M | 2.59M | 2.23M | 1.71M | 1.66M | 1.32M | 1.29M | 1.06M | 680.63K | 809.82K | 902.89K |
| R&D % of Revenue | 8313.82% | 13403.77% | 21989.41% | 733.89% | 6857.31% | 3829.59% | 565.08% | 1450.26% | 3023.23% | 3526.59% | 2637.86% | 1399.83% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.39M | -3.83M | -3.71M | -3.31M | -4.81M | -2.69M | -2.29M | -2.47M | -4.11M | -3.22M | -3.1M | -3.12M |
| Operating Margin % | -14612.57% | -19516.84% | -31432.3% | -1089.77% | -19230.14% | -6212.8% | -979.02% | -2770.83% | -11740.72% | -16687.46% | -10112.19% | -4831.86% |
| Operating Income Growth % | 29.57% | -42.2% | -62.18% | -33.88% | -16.99% | 16.47% | 26.33% | 20.78% | 28.89% | 31.21% | 32.65% | 32.67% |
| EBITDA | -3.39M | -3.77M | -3.66M | -3.25M | -4.76M | -2.64M | -2.24M | -2.42M | -4.07M | -3.18M | -3.06M | -3.08M |
| EBITDA Margin % | -14612.57% | -19247.27% | -30986.36% | -1072.38% | -19023.01% | -6096.47% | -958.36% | -2717.29% | -11618.68% | -16466.15% | -9974.91% | -4767.48% |
| EBITDA Growth % | 28.81% | -42.91% | -63.32% | -34.34% | -16.95% | 16.94% | 26.89% | 21.27% | 29.15% | 30.57% | 32.69% | 33.11% |
| D&A (Non-Cash Add-back) | 0 | 52.84K | 52.62K | 52.75K | 51.78K | 50.37K | 48.27K | 47.7K | 42.71K | 42.71K | 42.15K | 41.53K |
| EBIT | -3.39M | -3.83M | -3.71M | -2.66M | -4.81M | -2.69M | -2.29M | -2.47M | -4.11M | -3.22M | -3.02M | -5.71M |
| Net Interest Income | 0 | 34.59K | 57.74K | 73.92K | 99.97K | 118.99K | 158.55K | 175.94K | 162.6K | 200.15K | 61.67K | 96.19K |
| Interest Income | 0 | 34.59K | 57.74K | 73.92K | 99.97K | 118.99K | 158.55K | 175.94K | 162.6K | 376.22K | 61.67K | 96.19K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 176.07K | 0 | 0 |
| Other Income/Expense | 1.23M | 617.66K | 670.73K | 649.02K | -532.26K | 1.05M | 1.2M | -1.56M | 1.89M | 4.39M | 7.87M | -2.59M |
| Pretax Income | -2.15M | -3.21M | -3.04M | -2.66M | -5.34M | -1.64M | -1.09M | -4.03M | -2.22M | 1.17M | 4.77M | -5.71M |
| Pretax Margin % | -9298.25% | -16365.49% | -25748.11% | -875.79% | -21359.2% | -3778.63% | -467.22% | -4521.39% | -6352.16% | 6075.45% | 15531.79% | -8851.78% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -2.15M | -3.21M | -3.04M | -2.66M | -5.34M | -1.64M | -1.09M | -4.03M | -2.22M | 1.17M | 4.77M | -5.71M |
| Net Margin % | -9298.25% | -16365.49% | -25748.11% | -875.79% | -21359.2% | -3778.63% | -467.22% | -4521.39% | -6352.16% | 6075.45% | 15531.79% | -8851.78% |
| Net Income Growth % | 59.65% | -96.05% | -178.38% | 34.06% | -140.18% | -239.54% | -122.89% | 29.44% | 69% | 126.97% | 202.42% | -22.12% |
| Net Income (Continuing) | -2.15M | -3.21M | -3.04M | -2.66M | -5.34M | -1.64M | -1.09M | -4.03M | -2.22M | 1.17M | 4.77M | -5.71M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.24 | -0.36 | -0.33 | -0.30 | -0.64 | -0.21 | -0.13 | -0.50 | -0.33 | 0.25 | 1.04 | -1.47 |
| EPS Growth % | 62.5% | -71.43% | -153.85% | 40% | -93.94% | -184% | -112.5% | 65.99% | 82.9% | 121.01% | 181.25% | -14.84% |
| EPS (Basic) | -0.24 | -0.36 | -0.33 | -0.30 | -0.64 | -0.21 | -0.13 | -0.50 | -0.33 | 0.25 | 1.04 | -1.47 |
| Diluted Shares Outstanding | 8.99M | 8.88M | 9.12M | 8.74M | 8.36M | 7.76M | 8.12M | 8.12M | 6.67M | 4.71M | 4.57M | 3.89M |
| Basic Shares Outstanding | 8.99M | 8.88M | 9.12M | 8.74M | 8.36M | 7.76M | 8.12M | 8.12M | 6.67M | 4.71M | 4.57M | 3.89M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |